A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

September 13, 2024

Study Completion Date

December 31, 2024

Conditions

Insomnia

Interventions

DRUG

YZJ-1139 tablets

Oral dose 20 mg

DRUG

Ticagrelor Tablets

Oral dose 90 mg twice daily

Trial Locations (1)

Shulan (Hangzhou) Hospital, Huangzhou

All Listed Sponsors

lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT06671470 - A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter